Apyx Medical (APYX) to Release Quarterly Earnings on Wednesday

Share on StockTwits

Apyx Medical (NASDAQ:APYX) is scheduled to be posting its Q2 2019 quarterly earnings results after the market closes on Wednesday, August 7th. Analysts expect Apyx Medical to post earnings of ($0.18) per share for the quarter. Parties interested in registering for the company’s conference call can do so using this link.

Apyx Medical (NASDAQ:APYX) last issued its quarterly earnings data on Wednesday, May 8th. The company reported ($0.14) earnings per share for the quarter, topping the consensus estimate of ($0.18) by $0.04. Apyx Medical had a net margin of 224.06% and a negative return on equity of 12.25%. The business had revenue of $5.82 million during the quarter. On average, analysts expect Apyx Medical to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Shares of Apyx Medical stock opened at $6.68 on Tuesday. Apyx Medical has a twelve month low of $3.55 and a twelve month high of $8.89. The business has a 50-day simple moving average of $6.80. The firm has a market cap of $251.34 million, a PE ratio of -23.03 and a beta of 0.13.

APYX has been the subject of several analyst reports. Piper Jaffray Companies dropped their price objective on shares of Apyx Medical to $7.00 and set an “overweight” rating for the company in a research note on Wednesday, May 8th. Zacks Investment Research cut shares of Apyx Medical from a “buy” rating to a “hold” rating in a research note on Monday, July 22nd. TheStreet cut shares of Apyx Medical from a “c-” rating to a “d” rating in a research note on Monday, May 20th. Finally, ValuEngine upgraded shares of Apyx Medical from a “buy” rating to a “strong-buy” rating in a research note on Monday, April 29th. One equities research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $7.88.

About Apyx Medical

Apyx Medical Corporation, a medical technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates through two segments, Advanced Energy and original equipment manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue.

Recommended Story: The mechanics of the bid-ask spread in trading

Earnings History for Apyx Medical (NASDAQ:APYX)

Receive News & Ratings for Apyx Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Keybank National Association OH Purchases Shares of 15,561 Silgan Holdings Inc.
Keybank National Association OH Purchases Shares of 15,561 Silgan Holdings Inc.
Keybank National Association OH Acquires New Stake in CBIZ, Inc.
Keybank National Association OH Acquires New Stake in CBIZ, Inc.
Keybank National Association OH Grows Stock Position in Antero Midstream GP LP
Keybank National Association OH Grows Stock Position in Antero Midstream GP LP
Keybank National Association OH Trims Stake in Vanguard Value ETF
Keybank National Association OH Trims Stake in Vanguard Value ETF
Keybank National Association OH Purchases 2,905 Shares of iShares Edge MSCI USA Value Factor ETF
Keybank National Association OH Purchases 2,905 Shares of iShares Edge MSCI USA Value Factor ETF
Keybank National Association OH Lowers Stake in TransUnion
Keybank National Association OH Lowers Stake in TransUnion


© 2006-2019 Ticker Report